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ABSTRACT
Synthetic phenolic antioxidants (SPAs) are a class of compounds used to increase the
durability of polymers as well as to increase the shelf-life of food, cosmetics, and other personal
care items. Of these SPAs is 2,4-di-tert-butylphenol (2,4-DBP). 2,4-DBP is primarily used in
polyethylene crosspolymer pipes, which are now used as a replacement for the traditional copper
pipes for household water distribution. However, 2,4-DBP has been found to leach from these
pipes into the water, enabling a mode of exposure to humans. 2,4-DBP has been detected in
human urine, serum, but more importantly, maternal serum, placenta, and cord blood. These
findings lead to a question as to whether we should be concerned about the developmental
effects of 2,4-DBP. Other common SPAs such as BHA, BHT, and AO2246 disrupt endocrine
glands, the nervous system, and bone during embryonic development. As such, the goal of this
study was to examine whether 2,4-DBP can disrupt multiple pathways of development. Human
induced pluripotent stem (HiPS) cells were differentiated for up to 40 days along the myogenic
or osteogenic pathway. Cells were collected at multiple stages to assess changes in mRNA
expression of pathway-specific marker genes. Cells were also harvested for histochemistry and
protein expression. RNA sequencing was additionally conducted to identify signaling pathways
that were affected by exposure. The results indicate that 2,4-DBP exposure caused delays in
osteogenic differentiation as indicated by misexpression of the gene markers MEOX1, PAX9,
OPN, and RUNX2. RNA sequencing identified the canonical Wnt signaling pathway as a means
by which osteogenic differentiation was impacted. Misexpression of the WNT3A protein and
the CCDN1 gene further verify that osteogenesis was impacted. In conclusion, this study shows
that 2,4-DBP impairs osteogenic differentiation. As this compound has not been previously
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investigated before, this work elucidates the potential developmental toxicity this new SPA may
have on human health.
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CHAPTER 1
Introduction and Background Information
Synthetic Phenolic Antioxidants
Synthetic phenolic antioxidants (SPAs) are a class of chemicals utilized for polymer
materials such as plastic, rubber, and food products to enhance the durability and longevity of
products through trapping radicals and preventing oxidative damage. Examples of SPAs,
including AO2246 and butylated hydroxyanisole (BHA) (Figure 1), which are incorporated into
polyethylene, polypropylene, and polyvinyl chloride (Dopico-Garcia et al. 2007), while butylated
hydroxytoluene (BHT) and tert-butylhydroquinone (TBHQ) are directly added to food (de Jesus
et al. 2020; Xu et al. 2021). SPAs including 2,4-di-tert-butylphenol (2,4-DBP) are also
implemented into cross-linked polyethylene (PEX) water distribution pipes, which are increasing
in use as a replacement for traditional copper pipes in buildings (Lund et al. 2011). As such, the
use of SPAs is widespread and gives rise to concern as to whether they are contaminating the
environment and impacting human health.

Figure 1 - Structure and names of common SPAs (AO 2246, BHA, 2,4-DBP, BHT, TBHQ)
1

SPAs are routinely found in the environment as they have been detected in multiple
environmental samples. In sewage sludge, BHA, BHT, and AO2246 have been detected at levels
up to 2325 ng/g (Liu et al. 2015), river systems have SPA concentrations up to 871 ng/L (Rodil
et al. 2010; Liu et al. 2015), and indoor dust has been found to contain up to 118 µg/g of SPAs
(Wang et al. 2016). In effect, SPAs are highly ubiquitous and there are multiple pathways
through which humans may ingest or inhale these compounds.
2,4-Di-Tert-Butylphenol (2,4-DBP)
Among the SPAs used in polymer materials is 2,4-di-tert-butylphenol (2,4-DBP),
characterized by a phenol group containing two tert-butyl functional groups at the 2 and 4
position (Figure 1). This compound is added specifically to food packaging (Qian et al. 2018)
and plastic water distribution pipes. PEX pipes recently have replaced the traditionally used
copper pipes for water distribution (Lund et al. 2011). While PEX pipes present a solution to the
leaching of heavy metal contaminants in drinking water, PEX, as well as various forms of food
packaging, can leach 2,4-DBP into its water. 2,4-DBP is able to migrate from bottles and electric
kettles made from polyolefin, polypropylene, and silicone (Skjevrak et al. 2005; Onghena et al.
2014) and has been detected in drinking water emerging from PEX pipes up to 31 µg/L
(Loschner et al. 2011).
SPAs and Human Exposure and Effects
SPAs have been detected in various human samples. Liu & Mabury’s work in 2019
assessed levels of BHT and 2,4-di-tert-butylphenol (2,4-DBP) in human urine collected from
adults in the United States. This study found concentrations up to 0.853 and 25.8 ng/mL for BHT
and 2,4-DBP, respectively (2019). A study in Germany by Murawski et al. detected BHT in
urine of children and adolescents, ranging up to 248 µg/L (2021). Schmidtkunz et al’s study in
2

Germany also detected a metabolite of BHT, BHT acid, in urine samples up to 18.1 µg/L (2020).
In Wang & Kannan’s study from 2019, urine samples from China, India, Japan, Saudi Arabia,
and the United States were collected to be analyzed for SPAs. BHT was detected up to 15 ng/mL
and BHA up to 46 ng/mL (Wang & Kannan 2019). Furthermore, Wang et al. (2018) assessed 75
serum samples from pregnant women in San Francisco, CA, USA and detected over 80% of
samples had synthetic phenolic compounds, including 2,4-DBP (2018). While this study did not
explicitly state concentrations, it highlighted the widespread exposure of SPAs. In Du et al.’s
study in 2019, BHT, 2,4-DBP, and AO2246 were detected in plasma, placenta, and cord plasma
samples collected from pregnant women in China (2019). BHT was detected at levels up to 64.0,
6.58, and 7.07 ng/g, respectively. 2,4-DBP was detected at concentrations up to 4.01, 3.5, and
4.02 ng/g, respectively. Finally, AO2246 was found at levels up to 80.8, 69.7, and 25,7 ng/g,
respectively. As the detection of SPAs has been widespread in human samples, there implies a
great concern of SPAs’ toxicity on human health and development.
The toxicity of some SPAs, such as BHA and BHT, have been thoroughly studied over
the recent decades in both in vitro and in vivo models. However, their effects on developmental
processes is rather limited. BHT has been found to cause changes in locomotor behavior and
expression of the dopamine system of zebrafish exposed up to 10 µM (Liang et al. 2020). In
2018, a study by Yang et al. assessed the developmental toxicity of SPAs in zebrafish. Hatching
rates decreased in fish exposed to BHA. TBHQ, and AO2246. Larvae born from adults exposed
to either 200 µM BHT, 20 µM TBHQ, or 2 µM AO2246 were found with spinal curvatures,
pericardial edema, and uninflated swim bladders. BHA (20 µM) induced uninflated swim
bladders in larvae, as well. Adult rats fed 0, 25, 100, or 500 mg/kg body weight/day of BHT
produced offspring with significant hepatocellular adenomas and carcinomas (Olsen et al. 1986).
3

Jeong et al. investigated the developmental changes in offspring of adults rats fed BHA. Rats
were fed up to 500 mg/kg body weight/day and then bred. Offspring from the highest
concentration had reduced weight on PND 21, as well as increased liver and adrenal gland
weight by week 13 (Jeong et al. 2005). Taken together, SPAs appear to disrupt developmental
processes (Yang et al. 2018).
2,4-DBP and Human Exposure and Effects
2,4-DBP is one of the SPAs that has been detected in human samples, particularly in
pregnant and lactating women. Table 1 shows the types of human samples that have been found
to contain 2,4-DBP at concentrations up to 70 ng/mL and at a frequency of > 75%. It is
especially of great concern that this compound has been detected in pregnant women and their
placentas, as it is may be disrupting the growth and development of the fetus.
Table 1 – Concentrations of 2,4-DBP found in human samples.
Sample

Concentration

Detection Frequency (Number

Study

of Samples)
Urine

5.81-69.9 ng/mL

100% (n = 60)

Liu & Mabury 2019

Serum

Up to 14.8

92% (n = 25)

Liu & Mabury 2018

85% (n = 80)

Zhang et al. 2020

ng/mL
Breast Milk

Up to 61.6
ng/mL

Maternal Serum

Up to 4.01 ng/g

100% (n = 36)

Du et al. 2020

Cord Blood

Up to 3.50 ng/g

78% (n = 36)

Du et al. 2020

Placenta

Up to 4.02 ng/g

86% (n = 36)

Du et al. 2020
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Compared to most other high-volume SPAs, very little information is available on its
toxicity. Regarding its in vitro effects, 2,4-DBP has been only found to inhibit proliferation and
induce apoptosis in human gastric adenocarcinoma cells (Song et al. 2018). In newborn rats, 2,4DBP has been found to cause increase in liver weight and fatty degeneration of hepatocytes
when administered 40 mg/kg during initial periods of development after birth (Hirata-Koizumi et
al. 2005).
Human Induced Pluripotent Stem Cells
Human induced pluripotent stem (HiPS) cells are a cell model that originates from
reprogrammed fibroblasts to mimic embryonic stem cells. They can be differentiated into
multiple different cell types such as myoblasts and osteoblasts (Figure 2). As such, HiPS cells
serve as a viable in vitro model to simulate embryonic development.

Figure 2 – In vitro formation of osteoblasts and myoblasts from HiPS cells

5

The differentiation of HiPS cells is driven by sequences of growth factors specified for
the progression of one stage of development to the next. In this study, the two lineages which
HiPS cells will follow are osteogenesis and myogenesis. Skeletal muscle growth and
development begins with the formation of somites. Somitogenesis initiates the segmentation of
the body axis. Driven by FGF, Wnt, and Notch signaling, the mesoderm organizes itself into
segments of cells that serve as precursors to the axial skeleton and skeletal muscle tissue. As
such, somites are crucial in the organization and structure of a developing embryo (Maroto et al.
2012; Musumeci et al. 2015). Somite formation has been found to be well driven by CHIR, a
Wnt signaling growth factor, in combination with a BMP inhibitor, LDN-193189, and a TGF-ß
inhibitor, SB431542 (Xi et al. 2017; Tani et al. 2020).
Somite differentiation can be directed down the osteogenic pathway to form the
sclerotome. The sclerotome continues to drive the formation of the vertebrae. The induction of
Shh has been indicated to play a key role in the formation of the sclerotome (Buttitta et al. 2003).
The combination of Smoothened agonist, a Shh activator, and FGF, which enables the
MAPK/ERK pathway, allow for the formation of the sclerotome from somites to occur (Xi et al.
2017). Following the sclerotome is the formation of the osteoblast. Osteogenesis is driven by the
Wnt/β-catenin and MAPK/ERK pathways, driving the maturation of osteoblasts and thus skeletal
development (Chen et al 2007; Langenbach & Handschel 2013; Kim et al. 2019). Commonly,
osteogenic differentiation medium contains dexamethasone, ascorbic acid, and βglycerophosphate (Langenbach & Handschel 2013; Zhou et al. 2021). Dexamethasone promotes
cell proliferation and promotes differentiation by regulating RUNX2, a transcription factor that
plays a role in the Wnt and MAPK signaling pathways (Phillips et al. 2006; Hamidouche et al.
2008). Ascorbic acid initiates the secretion of collagen, which facilitates the phosphorylation and
6

MAPK-induced activation of RUNX2. Finally, β-glycerophosphate serves as a phosphate source
serving for the activation of the MAPK signaling pathway (Langenbach & Handschel 2013).
Somite mesenchymal cells can also differentiate to form dermomyotomal cells, an
intermediate stage of myogenesis. The dermomyotome plays a role in the formation of the
muscle that defines the back, rib cage, and limbs. The differentiation of the somite into the
dermomyotome is driven by two primary growth factors, CHIR and FGF. CHIR modulates Wnt
signaling and induces the development of the mesoderm (Shelton et al. 2014). FGF-signaling
enables MAPK/ERK driven muscle development (Delfini et al. 2009). Following the
dermomyotome stage is the formation of myocytes. At this stage of the myogenic pathway,
differentiation is driven by the growth factors HGF and IGF. HGF causes phosphorylation of
ERK, which leads to the migration of myoblasts to form myocytes (Gonazles et al. 2017). IGF
regulates the differentiation and proliferation of myoblasts into myocytes through driving the
PI3K/Akt pathway (Xu & Wu 2000).
In effect, iPS cells are able to differentiate into osteoblasts and myoblasts through
modulating signaling pathways with the use of specific sequences of growth factors. With 2,4DBP’s developmental impacts on human health being currently very limited in knowledge, HiPS
cells serve as an appropriate screening tool to understand how early stages of development are
affected by 2,4-DBP exposure.

Goal of the Study
The purpose of this study is to assess the effects of 2,4-DBP on the osteogenic and
myogenic differentiation of HiPS cells. Because 2,4-DBP’s toxicity is not known, and given its

7

presence in maternal serum, cord blood, and placenta, it is crucial to understand its effects on
embryonic growth and development. HiPS cells will be differentiated into osteoblasts and
myocytes to simulate how bone and skeletal muscle formation may be disturbed by 2,4-DBP
exposure, as spinal curvatures have been previously shown following exposure to BHT, TBHQ,
and AO2246 (Yang et al. 2018). It is hypothesized that 2,4-DBP will inhibit development by
slowing the rate of differentiation into somites (Schroter et al. 2008; Maroto et al. 2012, Xi et al.
2017), thus impairing both the myogenic and osteogenic pathways. The overall goal of this
study is to elucidate the potential effects an understudied anthropogenic contaminant may have
on human development.

Specific Aims
Aim #1 – Investigate the Potential Delays in Osteogenic Differentiation of HiPS cells by 2,4DBP Exposure
Osteogenic differentiation is characterized by the sequence of somite-like cells,
sclerotomal cells, and osteoblast formation, ultimately leading to formation of bone tissue. HiPS
cells will be exposed to 0, 0.25, 0.5, and 1.0 µM DBP for either 6 days to assess the impact of
DBP on pluripotency, or for up to 40 days during osteogenic differentiation. Every 2 days of
differentiation, cultures will be imaged for morphological assessment. At each of these stages
(iPS cells, Day 4 for somite-like cell, Day 6 for sclerotomal-like cells, Day 40 for osteoblasts),
expression of various gene markers (OCT4 and NANOG for iPS cells, MEOX1 for somite-like
cells, PAX1 and PAX9 for sclerotomal-like cells, RUNX2, COL1A1 and OPN for osteoblasts) will
be conducted through qPCR to assess the progression of cells. Day 40 cells will be stained with
Alizarin Red to visualize calcium deposits, a measure of mature osteoblasts.
8

Aim #2 – Investigate the Potential Disruptions in Myogenic Differentiation of HiPS Cells
Caused by 2,4-DBP exposure
Myogenic differentiation consists of the formation of somite-like cells, dermomyotomal
cells, and then myocytes to form skeletal muscle tissue. HiPS cells will be exposed to the same
levels of DBP as stated in Aim #1 for the entire duration of myogenic differentiation over 40
days. Morphology will be assessed every 2 days. qPCR will be conducted to assess the
expression of TBX6 in somites, PAX3 in dermomyotomes, and PAX3, MYOD, and MYOG in
myocytes in order to determine the impacts of DBP exposure on this pathway. In addition to
qPCR, immunofluorescence staining of myocytes for myosin heavy chain (MyHC) protein will
be conducted to assess the progression of myogenesis.

Aim #3 – Assess the Wnt Pathway in HiPS somite cells exposed to DBP during
differentiation
To further determine the impacts of DBP on gene expression, RNA collected from the
control and 1.0 µM DBP exposure group at the somite-like, sclerotome-like, and 34-day myocyte
stages will be analyzed by RNA sequencing. Results will indicate what transcriptional changes
occur during differentiation and enable us to focus on how DBP impacts specific pathways. We
will focus our efforts on examining the somite-like cell stage and how the canonical Wnt
signaling pathway is impacted using a combination of immunoblotting and qPCR.
The overall goal of this work is to determine whether an understudied synthetic
contaminant may impair development and growth. I hypothesize that 2,4-DBP will hinder
osteogenic and myogenic pathways through reducing rates of differentiation, thus preventing
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target cells from being formed properly. The results will further our understanding of SPAs and
their potential role as a developmental toxicants.
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Abstract
2,4-di-tert-butylphenol (2,4-DBP) is a synthetic antioxidant used to increase the durability of
plastic products, including polyethylene crosspolymer (PEX) pipes, which have been used as a
replacement for traditional metal water distribution pipes. 2,4-DBP can leach from PEX pipes
and has been found in human samples, including breast milk, cord blood, and placenta, giving
rise to the concern that this compound may interfere with fetal development. As such, the
objective of this study is to assess the impacts of 2,4-DBP on cellular differentiation. Induced
pluripotent stem cells were differentiated into osteoblasts or myoblasts over the course of 40
days and analyzed for markers of somitogenesis and myoblast or osteoblast development.
Myogenesis was not significantly impacted by exposure. Somite-like cells exposed to 1.0 µM
2,4-DBP downregulated MEOX1 and TBX6 transcripts by 5-fold and 2-fold, respectively.
Markers for pluripotency, NANOG and OCT4, were in turn upregulated in a dose dependent
manner. At the sclerotome-like stage, PAX9 mRNA decreased by 2-fold in the 0.5 µM and 1.0
µM treatments. In osteoblasts, OPN increased in a dose dependent manner, whereas RUNX2
decreased by 2-fold in the 0.5 µM and 1.0 µM treatments. Alizarin Red staining of calcium
deposits in Day 40 osteoblasts were decreased in the 0.5 µM and 1.0 µM treatment groups.
Overall, this study shows that 2,4-DBP can delay key processes during sclerotome and osteoblast
development, leading to potential for bone-related disease in exposed individuals.

Key words: 2,4-di-tert-butylphenol, osteogenesis, myogenesis, developmental toxicity, human
induced pluripotent stem cells
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Introduction
Synthetic phenolic antioxidants (SPAs) are a class of anthropogenic chemicals used to
slow the degradation of consumer products. They are widespread and found in a multitude of
both household and industrial products, including plastics, pharmaceuticals, cosmetics, and food
products (Liu et al. 2015). As SPAs are not chemically bonded to their material substrate, they
are able to leach from products into the environment (Liu & Mabury 2020). SPAs have been
found in indoor dust, wastewater, and sewage sludge (Rodil et al. 2010; Liu et al. 2015; Wang et
al. 2016). One SPA is 2,4-di-tert-butylphenol (2,4-DBP), an antioxidant used in food packaging
and polyethylene crosspolymer (PEX) pipes (Lund et al. 2011; Qian et al. 2018; Kato & ConteJunior 2021). PEX pipes have been used as a replacement for the previously traditional copper
pipes that can leach toxic metals into drinking water. However, 2,4-DBP can leach from a variety
of plastic pipes, including PEX, polypropylene, and polybutylene, leading to drinking water
containing up to 26 µ/L (Lund et al. 2011). Water in polyolefin bottles have been shown to
contain 2,4-DBP in concentrations up to 25 µg/L. (Skjevrak et al. 2005).
Human serum, urine, placenta, and cord blood have been found to contain a variety of
SPAs, including BHT, AO2246, and 2,4-DBP (Liu & Mabury 2018; Wang et al. 2018; Du et al.
2019; Liu & Mabury 2019; Wang & Kannan 2019; Schmidtkunz et al. 2020; Murawski et al.
2021). 2,4-DBP was found in 100% of 60 urine samples at concentrations up to 69.6 ng/mL in
Liu & Mabury’s study from 2019. Liu & Mabury also conducted a study in 2018 which detected
2,4-DBP ranging up to 14.8 ng/mL. Zhang et al.’s study of breast milk samples found 85% of the
80 collected samples to contain 2,4-DBP, reaching levels up to 61.6 ng/mL (2020). In a report by
Du et al., 2,4-DBP was found in 100% of serum samples taken from 36 pregnant women at
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concentrations up to 4.0 ng/g. Furthermore, 78% of cord blood samples and 86% of placenta
samples were detected with 2,4-DBP at levels up to 3.5 ng/g and 4.0 ng/g, respectively (2019).
More widely known SPAs like BHT, BHA, and AO2248 have been shown to cause
spinal curvature and pericardial edema in zebrafish after 5 days of development (Yang et al.
2018). Sarmah et al. observed embryos exposed to BHT exhibiting abnormal pivoting of the
spine 96 hours post-fertilization (2020). However, what is currently known about 2,4-DBP is
quite limited. 2,4-DBP is naturally found in algae and various plant species, and has been studied
for its antioxidant effects. A study by Vahdati et al. detected 2,4-DBP in Chlorella and found
that the algal extract reduce H2O2-induced oxidative stress in PC12 cells (2022). The compound
has also been found in H. unijuga and has exhibited anti-inflammatory and anticancer properties
in MCF-7 and A431 cell lines (Nair et al. 2020). However, at higher concentrations, 2,4-DBP has
been found to cause weight loss, increase in liver and kidney weights, and increase death in
newborn rats when fed 300 mg/kg/day for 7 days (Hirata-Koizumi et al. 2005). With its detection
in maternal serum, cord blood, and placenta, what makes 2,4-DBP particularly concerning is the
lack of knowledge regarding its toxicity to human development.
HiPS cells are an in vitro model used to investigate how development can be impacted by
exposure to an environmental contaminant. These cells can be directed down the osteogenic and
myogenic differentiation pathways to form osteoblasts and skeletal myocytes, both which can
simulate how anatomy may be impacted during development (Xi et al. 2017). Aikawa conducted
a screening test for developmental toxicity using HiPS cells, inducing cardiomyogenesis while
exposing the cells to known teratogens. This study observed increased differentiation time
required for cardiomyocytes to form when exposed to thalidomide (2020). Similarly, Lauschke et
al. induced cardiomyogenesis in HiPS cells while exposed to thalidomide, valprioic acid, and
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epoxiconazle and observed impaired function of the formed myocytes (2020). As such, HiPS
cells can serve as a useful model in predicting human developmental toxicity.
The goal of this study is to investigate the developmental toxicity of 2,4-DBP using HiPS
cells as a model. HiPS cells were differentiated while being exposed to 2,4-DBP for up to 40
days down the osteogenic and myogenic pathways. The results indicate that 2,4-DBP can delay
formation of somites, sclerotome, and osteoblasts.

Materials and Methods
HiPS Cell Culture and Differentiation
HiPS cells (#ATCC- DYS0100, Manassas, VA, USA) were cultured in mTeSR-1 media
(StemCell, Vancouver, Canada) in 6-well plates coated with Matrigel (Corning) with daily media
changes. Cells were cultured in a humidified incubator at 37°C with 5% CO2, and passaged every
5-7 days using ReLeSR reagent (StemCell). Supplementary Figure 1 illustrates the
differentiation scheme for both pathways in this study, while Supplementary Table 1 lists the
small molecules and growth factors used during differentiation. HiPS cells were exposed to 0,
0.25, 0.5, and 1.0 µM throughout the differentiation periods. On Day -1, HiPS cells were
dissociated with ReLeSR and seeded on 6-well Matrigel coated plates (10 x 104 cells/well) with
mTeSR-1 containing 10 µM Y-27632 ROCK inhibitor. On Day 0, for both osteogenic and
myogenic pathways, media was switched to basal differentiation medium (BDM; DMEM/F-12
containing 1X PenStrep and 1% ITS) that also included 3 µM CHIR. On Day 2, media was
switched to BDM containing 200 nM LDN and 10 µM SB. For osteogenesis, on day 4, cells
were dissociated and seeded on new plates at 20 x 104 cells/well in BDM containing 20 ng/mL
FGF and 300 nM SAG. On Day 6, media was switched to osteogenic media (Alpha MEM
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containing 15% FBS, 1% NEAA, 0.1 mM 2-mercaptoethanol, 1X PenStrep, 5 µg/mL ascorbic
acid, 10 nM sodium glycerophosphate, 10-8 M dexamethasone) for 34 days. For myogenesis, on
day 4, media was switched to BDM containing 3 µM CHIR and 20 ng/mL FGF. On day 6, media
was switched to myogenic media (DMEM containing 15% KSR, 1X PenStrep, 10 ng/mL HGF, 2
ng/mL IGF) for 34 days. Media was changed daily until Day 6, after which media was changed
every other day (Xi et al. 2017; Zhou et al. 2021).

Supplementary Figure 1. Procedure, timeline, growth factors, and markers used in iPS
differentiation into myoblasts and osteoblasts. A. Each box indicates cell type, along with the
stage specific gene marker or histochemical analysis performed. Arrows and adjacent text
indicate growth factors and timeline. B. Cells will be exposed to 0, 0.25, 0.5, or 1.0 µM 2,4-DBP
throughout differentiation.
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Supplementary Table 1 – Growth factors and supplements used throughout myogenic and
osteogenic differentiation
Growth Factor

Provider

Differentiated cell

Role

types
CHIR

StemCell

3 µM

Somite-like

Wnt Signaling Factor

mesenchymal cells,

(GSK-3β inhibitor)

dermomyotomal
cells
LDN

Sigma

200 nM

Aldrich
SB

Sigma

10 µM

Aldrich
Fibroblast

Sigma

Growth Factor

Aldrich

Somite-like

ALK2 + ALK3

mesenchymal cells

inhibitor

Somite-like

p38 MAPK inhibitor

mesenchymal cells
20 ng/mL

Dermomyotomal,

Activates FGF

Sclerotomal cells

signaling, involved in

(FGF)

MAPK/ERK pathway;
Induces formation of
tendon progenitor

Hepatocyte

Sigma

Growth Factor

Aldrich

10 ng/mL

Myoblasts

MAPK/ERK
phosphorylation

(HGF)
Insulin Growth

Sigma

Factor (IGF)

Aldrich

2 ng/mL

Myoblasts

Induces proliferation
and differentiation of
myoblasts through
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PI3K/Akt pathway
activation
Knockout Serum

Gibco

15%

Myoblasts

Serum Supplement

Millipore

300 nM

Sclerotomes

Sonic Hedgehog

Replacement
(KSR)
Smoothened
Agonist (SAG)

Pathway signaling
agonist

Ascorbic Acid

Fisher

5 µg/mL

Osteoblasts

Scientific
Dexamethasone

MP

Collagen secretion for
MAPK Activation

10-8 M

Osteoblasts

Biomedicals

Wnt + MAPK
signaling through
Runx2 regulation

Sodium

Thermo

10 mM

Osteoblasts

MAPK Activation

0.1 M

Osteoblasts

Mineralization

Glycerophosphate Fisher
2-

Gibco

Mercaptoethanol

Cultures were imaged every 2 days to assess morphological changes, harvested in Trizol
(Sigma Aldrich), on Days 4, 6, and 40 for gene expression analysis of somite mesenchymal cells,
sclerotomal or dermomyotomal cells, and osteoblasts or myoblasts, respectively. An additional
set of cells was cultured as above for 40 days, and then fixed in 4% paraformaldehyde for
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histochemistry. A final set of HiPS cells were cultured in mTeSR-1 containing up to 1 µM 2,4DBP for 6 days to assess changes in pluripotency.

Osteogenesis Cytotoxicity Assay
To determine cell viability and apoptosis in osteoblasts, SyTox green and Annexin V
staining was conducted. On day 40, osteoblasts were collected using Accumax (StemCell) and
suspended in FACS buffer (1X PBS, 1% BSA, 0.1% sodium azide) Cells were incubated with
with Annexin V (Santa Cruz Biotechnologies; sc-74438; 1:200) followed by an Alexa Fluor 568
secondary antibody (Invitrogen; A1104; 1:400) to assess apoptotic cells. After washing, cells
were incubated with SyTox Green (Invitrogen) to assess the number of living cells by flow
cytometry using a Bio-Rad S3e Cell Sorter. Gates were used to exclude debris and doublet cells,
and fluorescence examined at 488 nm excitation and 504 nm emission for SyTox green, and 561
nm excitation and 603 nm emission for Annexin V.

Gene Expression Analysis
RNA was extracted, and purity (A260/280) and concentration determined on a Nanodrop
(Thermo Scientific). Reverse transcription was conducted using 2µg RNA, 10 mM
deoxynucleotides, 50 ng/µL random hexamers, and murine Moloney leukemia virus reverse
transcriptase (Promega). Expression of stage specific target genes was determined utilizing real
time quantitative polymerase chain reaction (qPCR; Bio-Rad CFX96; Hercules, CA, USA).
Primer sequences for each target gene are in Supplementary Table 2. GAPDH and B2M served
as housekeeping genes. Samples were run in triplicate, and efficiency and accuracy of reactions
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were assessed using a 5 point standard curve of serial dilutions (10-3 to 10-7 ng/µL DNA) as well
as a negative control. Melt curves were assessed to ensure lack of non-specific primer binding.
To assess fold expression relative to controls, the Delta-Delta Ct method was utilized
(Schmittgen & Livak, 2008). Statistical significance of gene expression between control and 2,4DBP exposed cells (n = 6 samples per stage and exposure group) was determined using ANOVA
followed by Tukey’s post-hoc test.

Supplementary Table 2. Primers used during HiPS Cell Differentiation into Osteoblasts and
Myoblasts.
Marker

Cell type

Sequence

Tm

GAPDH

Housekeeping

F-CCCTTCATTGACCTCAACTAC

56°C

R-ATGACAAGCTTCCCGTTCTC

B2MG

Housekeeping

F-CAGCAAGGACTGGTCTTTCTAT

56°C

R-ACATGTCTCGATCCCACTTAAC

NANOG

HiPS Cell

F-TGAAATCTAAGAGGTGGCAGAA

55°C

R-CCTGGTGGTAGGAAGAGTAAAG

OCT4

HiPS Cell

F-CCTGAAGCAGAAGAGGATCAC

55°C

R-AGATGGTCGTTTGGCTGAATA

MEOX1

TBX6

Somite-like

F-GAGTTCAGACAACCAGGAGAAC

mesenchymal cells

R-AGCCGAGTCAGGTAGTTATGA

Somite-like

F-CTACCAGAACCCACAGATCAC 56°C

mesenchymal cells

R-CTCGCTCCCTCTTACAGTTTC

24

55°C

CCND1

PAX1

Somite-like

F-CCTCGGTGTCCTACTTCAAATG

mesenchymal cells

R-CACTTCTGTTCCTCGCAGAC

Sclerotomal cells

F-ACACTCGGTCAGCAACATC

57°C

54°C

R-CTTCCATCTTGGGAGAGTAAGC

PAX9

Sclerotomal cells

F-GTACGGTCAGGCACCAAAT

54°C

R-CAGCACTGTAGGTCATGTAAGG

PAX3

RUNX2

Dermomyotomal

F-AAGAGGAAACAGCGCAGAAG

cells; Myoblast

R-FFCCATTCCTCCCTAGTATAA

Osteoblast

F-CAGATGGGACTGTGGTTACTG

54°C

56°C

R-AGATCGTTGAACCTTGCTACTT

COL1A1

Osteoblast

F-CTAAAGGCGAACCTGGTGAT

56°C

R-TCCAGGAGCACCAACATTAC

OPN

Osteoblast

F-CATATGGCCGAGGTCATAG

58°C

R-AGGTGATGTCCTCTCTGTA

MYOD

Myoblast

F-CCACAACGGACGACTTCTATG

58°C

R-GAGTGCTCTTCGGGTTTCAG

Histochemistry
To further assess the formation of osteoblasts, Alizarin Red staining was conducted on
day 40 cells to detect calcium deposition. Cells were fixed in 4% paraformaldehyde and
incubated in 40 mM Alizarin Red for 30 minutes. Wells were imaged using an inverted
microscope. Alizarin Red levels were quantified following extraction of stain from cells using
10% acetic acid, followed by neutralization with 10% ammonium hydroxide. Absorbance was
assessed via spectrophotometery at 405 nm (Gregory et al. 2004). Differences in Alizarin Red
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levels between control and 2,4-DBP exposed cells (n = 6 samples per exposure group) was
determined using ANOVA followed by post-hoc test.
For myocytes, immunofluorescence staining was conducted to detect the presence of
myosin heavy chain (MyHC). After 40 days of culturing in glass bottom Wilco culture dishes,
myocytes were fixed in 4% paraformaldehyde, permeabilized with 0.2% Triton X-100 in PBS,
blocked in 1% BSA in PBST, and then incubated with a myosin heavy chain primary antibody
(#BAF8; DSHB; 1:10 dilution), followed by an Alexa Fluor 488 secondary antibody (Life
Technologies; 1:20 dilution). Nuclei were counterstained with DAPI (EMD Millipore), and cells
were imaged with a Leica SPX confocal microscope using a 20X objective. Staining intensity
was analyzed using Leica LAS-X software.

RNA Sequencing
In order to determine additional transcriptional changes as a result of 2,4-DBP exposure
during differentiation, RNA sequencing was conducted (Novogene). From the somite,
sclerotome, and myocyte stages, equal quantities of RNA from two replicates were pooled into
one sample, giving an n = 3 per stage and exposure group. RNA quality was assessed by
Nanodrop and an Agilent 2100 Bioanalyzer. After sequencing, quality control, and falsediscovery rate correction, differential gene expression was then quantified using DESeq2 and
edgeR. GO and KEGG enrichment analyses next were run using ClusterProfiler in order to
statistically assess, classify, and visualize the profile of genes and gene clusters that are impacted
by 2,4-DBP exposure.
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Immunoblotting
Analysis of RNA sequencing data indicated that at the somite stage, genes from the Wnt
signaling pathway were impacted by 2,4-DBP exposure. The genes specified from the analysis
that are relevant to the osteogenic pathway were WNT5A, WNT4, and WNT3A. Therefore,
WNT3A and β-catenin protein levels were assessed by Western blots. HiPS cells were grown in
6-well plates, exposed to 0, 0.5, and 1 µM 2,4-DBP during somite formation as described above.
After 4 days, cells were lysed in RIPA buffer containing protease and phosphatase inhibitors
then centrifuged at 15,000g for 15 minutes at 4oC. Protein levels were quantified using the
Bradford assay (BioRad; Hercules, CA) and 10 µg of protein was electrophoresed onto SDS
PAGE gels. Following transfer, blots were incubated with antibodies to β-catenin (Cell
Signaling; #9561; 1:1000) and WNT3A (Novus; #NBP1-7483; 1:1000), along with a
corresponding secondary HRP-conjugated antibody (Santa Cruz; 1:2000). GAPDH antibody
was used as a loading control (Genetex; #GT239; 1:1000). Proteins were detected using Luminol
reagent (Santa Cruz), and expression quantified with a BioRad ChemiDoc.

Results
2,4-DBP exposure downregulates markers of formation of somite-like cells
Human iPS cells were exposed to up to 1 µM 2,4-DBP over a 40 day period to determine
whether it impaired osteogenic and myogenic differentiation . At each stage of differentiation,
cells were imaged to assess morphology and the expression of gene markers was assessed. Cells
at the first stage of forming somite-like mesenchymal cells do not show any visual differences in
morphology between the control and 1.0 µM treatments (Figure 1A,B). At this stage, levels of
MEOX1 and TBX6 were examined. MEOX1 is required to maintain sclerotome polarity and
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plays a role in the formation of the cranio-cervical joints (Skuntz et al. 2010), while TBX6 is
mportant in the formation of the ventral body wall muscle (Tazumi et al. 2008). MEOX1
expression decreased significantly by 5-fold in somites exposed to 1.0 µM 2,4-DBP (Figure 1C),
while TBX6 expression was reduced in the 1.0 µM group by 2.5-fold (Figure 1D). Since markers
of somite formation were reduced, we wanted to determine whether the cells remained
undifferentiated. Indeed, the expression of NANOG was increased dose dependently by 1.5- and
1.8-fold (Figure 1E), and OCT4 expression increased by 5.7-fold in the 1.0 µM 2,4-DBP
exposure group (Figure 1F).

Formation of dermomyotomal cells, but not myoblasts, is impacted by 2,4-DBP
Following the somitogenesis stage in myogenesis is the formation of the dermomyotome.
At this stage, dermomyotomal cells did not present any visible differences in morphology
between the control level and the 1.0 µM treatment (Figure 2A,B). The marker for
dermomyotomal cells is PAX3 (Gouldin et al 1994). In skeletal myogenesis, PAX3 is required in
the formation of hypaxial muscle which lays against the vertebrae (Ridgeway & Skerjanc, 2001).
Transcript levels decreased in a dose-dependent manner, as they were reduced by 1.4- and 10fold in the 0.5 µM and 1.0 µM exposure groups, respectively (Figure 2C).
Dermomyotomal cells were further differentiated for another 34 days into myocytes.
Morphological assessment does not show differences between control and 1.0 mM 2,4-DBP
exposure (Figure 3A,B). To assess whether 2,4-DBP exposure throughout the differentiation
period impacted myocyte formation, transcript levels of PAX3, MYOD, and MYOG were
assessed (Johanson et al. 1999; Seale et al. 2000 Zhang et al. 2020). MYOD plays a role in the
differentiation and fusion of myoblasts to form myotubes, whereas MYOG plays a role later in
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the pathway to drive the formation of myofibers (Zhang et al. 2020). PAX3 expression did not
significantly vary between exposure concentrations (Figure 3C). MYOD showed no distinct
trends and no significant changes between treatment levels (Figure 3D). MYOG expression
presented no pattern or significance throughout 2,4-DBP concentrations (Figure 3E).
Immunohistochemistry was used to determine whether the formation of myosin heavy chain
(MHC) was impacted by exposure to 2,4-DBP. MHC expression was abundant in the
differentiated cells. Similar to the transcripts, there was no change in the levels of MHC between
control and exposure groups (Figure 3F).

Osteogenesis is delayed by exposure to 2,4-DBP
Somite-like cells were differentiated for another 2 days to form sclerotomal cells.
Markers for this stage include PAX1 and PAX9 (Peters et al. 1999). PAX1 and PAX9 is
particularly important in the formation of the limbs and skull (Mise et al. 2008) and code for
proteins that are part of the DNA binding domain which regulates genes involved in
embryogenesis (Peters et al. 1999). The morphology of sclerotomal cells did not vary between
the control and the 1.0 µM treatment (Figure 4A, B). PAX1 mRNA expression was not different
between the control 2,4-DBP exposure (Figure 4C), while PAX9 expression decreased in the 0.5
µM and 1.0 µM levels significantly by 2-fold change (Figure 3D).
Next, the sclerotomal cells were differentiated into osteoblasts for a total of 40 days while
exposed to 2,4-DBP. OPN, COL1A1, and RUNX2 mRNA expression levels were assessed to
determine the progression of osteoblast formation (Sodek et al. 1995; Dacic et al. 2001;
Schroeder et al. 2005). Osteopontin (OPN) is a marker for early osteoblast formation as well as
the early stages of bone formation (Sodek et al. 1995). OPN expression showed a dose dependent
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increase with significant 4.6-fold change in the 1.0 µM group compared to the control (Figure
5C). COL1A1 expression in osteogenesis is indicative of the formation of type 1 collagen
(Rahkonen et al. 2003) and is one of the genes included in the DNA-binding domain of Runx2
(Maruyama et al. 2007). Unexpectedly, COL1A1 expression was not changed between control
and exposure groups (Figure 5D). In osteogenesis, RUNX2 is responsible for osteoblast
maturation and mineralization (Phillips et al. 2005) through coding for the Runx2 protein, a key
transcription factor involved in the cascade of genes relevant to skeletal development (Maruyama
et al. 2007). RUNX2 expression decreased significantly in the 0.5 µM and 1.0 µM groups, by
2.5- and 3.3-fold change, respectively (Figure 5E).

Calcium deposition in 40-day osteoblasts decreases from 2,4-DBP exposure, but cell
viability does not change
At day 40 of the osteogenic differentiation exposure, cells were stained with Alizarin Red
Stain (ARS) to detect the formation of calcium deposits during mineralization. The control and
0.25 µM treatment level showed no visible difference in pigmentation, while the 0.5 µM and 1.0
µM groups showed decreased amounts of staining (Figure 6A-D). ARS was then extracted from
cells in order to quantify the levels of calcium deposition. Concentrations of ARS were highest in
the control and 0.25 µM samples with levels up to 3.8 mM, while ARS concentrations in the 0.5
µM treatment was significantly lower. The 1.0 µM treated cells, while not statistically
significant, showed decreased levels of ARS (Figure E). It is important to mention that the
Matrigel and osteoblasts in the 1.0 µM treatment were peeling off the plate towards the end of
the 40-day exposure. As such, the lack of statistical significance between the 1.0 µM group and
the control may inaccurately reflect the changes in calcium deposits from 2,4-DBP exposure.
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In order to assess whether the lack of calcium deposits was a result of cell death or
delayed differentiation, flow cytometry with Sytox Green and Annexin V was used (Figure
6F,G). Results indicated no significant differences between the percentage of viable cells in the
control compared to the 0.5 and 1.0 µM treatments (Figure 6H). Furthermore, the percentage of
apoptotic cells out of the nonviable cells did not significantly differ between the control and the
0.5 and 1.0 µM exposures (Figure 6I).
2,4-DBP exposure alters the Wnt signaling pathway in somite-like cells
Since 2,4-DBP appears to hinder differentiation of iPS cells, we used RNAseq to begin to
understand the mechanisms behind this impairment. RNA samples from somite-like cells,
sclerotome-like cells, and myoblasts were sequenced to identify genes that are significantly
altered in expression between the control and 1.0 µM 2,4-DBP exposure groups. Initial analysis
of RNA sequencing data generated a PCA 3D plot (Figure 7A) that indicated the somite stage to
have the most variation in transcriptional changes between the control and 1.0 µM. Therefore,
we focused our efforts on examining differential gene expression at the somite stage. GO
analysis showed that somites exposed to 2,4-DBP had significant changes in the expression of
genes relevant to skeletal system development, regulation of the Wnt signaling pathway, and the
canonical Wnt signaling pathway (Figure 7B). The Wnt pathway has been indicated as a
contributor of bone formation (Xu et al. 2014) and WNT3A specifically induces the activity of
alkaline phosphatase, a key marker of early osteogenesis (Si et al. 2006). β-catenin is the
downstream transcription factor of the canonical Wnt pathway (He et al. 2015). The proteins
WNT3A and β-catenin were analyzed through immunoblotting (Figure 7C,D). Results of the
WNT3A blot indicated no significant changes in expression of WNT3A, though an overall dosedependent upward trend was observed (Figure 7E). β-catenin expression was reduced in the 0.5
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µM treatment group but no significant change in the 1.0 µM group (Figure 7F). Following
assessing the expression of these proteins, the expression of the gene CCDN1 was determined
through qPCR (Figure 7G). CCDN1 is a gene induced by the Wnt signaling pathway as well as a
marker for the early stages of osteogenesis (Chen et al. 2014). The 1.0 µM treatment level
showed a significant increase in expression compared to the control.

Discussion
The results of this study show that while 2,4-DBP may not impact myogenesis, it has the
ability to disrupt osteogenic differentiation in HiPS cells by decreasing the expression of
MEOX1 and RUNX2, and increasing expression of OPN. In addition to transcriptional changes,
calcium deposit formation decreased in osteoblasts treated with 2,4-DBP. Furthermore, RNAseq
identified disruption in the Wnt signaling pathway to be a means of which 2,4-DBP inhibits
differentiation at the somite stage.

Osteogenesis is disrupted by 2,4-DBP exposure
HiPS cells exposed to 2,4-DBP throughout osteogenic differentiation showed decreased
activity of MEOX1, PAX9, RUNX2 and increased expression of OPN. All transcripts play a key
role in the development and maturation of osteoblasts. For example, MEOX1 is vital in the
formation and segmentation of somites, which precedes the formation of the vertebrae (Rodrigo
et al. 2004). MEOX1 also drives the formation of the sclerotome (Rodrigo et al. 2004) and is
required to maintain sclerotome polarity (Skuntz et al. 2010). MEOX1 mutations have been
correlated with the risk of Klippel-Feil syndrome, which is characterized by fusion of the
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vertebrae that leads to an abnormally short neck and significant mobility restriction (Mohamed et
al. 2013). Dauer et al. further found that MEOX1 deficient zebrafish had fused vertebrae in the
adults (2018). In our study with differentiating iPS cells, MEOX1 transcripts were decreased as
a result of exposure to 1.0 µM 2,4-DBP, which suggests that somite and sclerotome formation is
inhibited following exposure.
Next, we focused on the sclerotomal stage and indeed did find that PAX9, a marker of
sclerotome formation (Peters et al. 1999; Mise et al. 2008), was downregulated in a doseresponsive manner following 2,4-DBP exposure. What was also observed at this stage was the
lack of change in PAX1 expression. PAX1 and PAX9 work synergistically to enable patterning
and differentiation of the sclerotome and contribute to the formation of the axial skeleton
(Sivakamasundari et al. 2017). Both genes coding for proteins contributing to the paired box
DNA binding domain and are noted to have similar functions in tissues (Peters et al. 1999).
Within this role, however, is the ability of the two genes to be able to compensate for one another
when downregulation or lack of activity occurs (Peters et al. 1999; Sivakamasundari et al. 2017).
As such, PAX1 transcripts not changing as PAX9 expression decreases may be an attempt to
rescue and maintain sclerotome proliferation and differentiation. This is supported by the lack of
morphological differences in sclerotomal cells exposed to 2,4-DBP compared to the control.
Furthermore, the activity of these two markers are localized in separate regions of the
sclerotome. PAX1 is found to be active in the ventromedial area, which later forms the anulus
fibrosus, which supports the vertebrae through connecting the discs throughout. In contrast,
PAX9 is active in the dorsal and lateral parts, which form the vertebral tendons and ligaments
(Mise et al. 2008; Tani et al. 2020). As such, it is possible that 2,4-DBP may selectively impact a
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particular region of the sclerotome at this stage of differentiation but still overall target
osteogenesis.
After forming sclerotomal cells, we next differentiated them into osteoblasts and
collected mRNA after 40 days to examine the gene markers OPN and RUNX2. RUNX2 is
responsible for osteoblast differentiation and proliferation and is one of the main drivers of
osteogenesis (Schroeder et al. 2005; Bruderer et al. 2014). RUNX2 knockout mice have a
complete absence of calcification throughout the body and, thus, a complete lack of bone
(Takarada et al. 2013). Exposure to chemicals can lead to the downregulation of RUNX2.
Selenomethionine-exposed medaka embryos had less RUNX2 activity and, as a result, decrease
in bone development and less calcification in the vertebrae (Wang et al. 2020). Overall, the
observed downregulation of RUNX2 observed in the 2,4-DBP-treated HiPS cells implies that
exposure over time will lead to deformities in the vertebrae.
OPN acts in osteoblasts and osteoclasts to inhibit mineralization (Zurick et al. 2012;Yuan
et al. 2014). The increased expression of OPN in the 1.0 µM treated osteoblasts corresponds with
the decreased calcium deposits in the cells of the same exposure level. While OPN is also
expressed in the later stages of osteogenesis such as in osteocytes, the decreased RUNX2
expression and decrease in calcium deposits in the exposed cells infers that the increased OPN
activity is likely an indicator of disruptions in mineralization. Exposure to other contaminants
can yield similar effects. For example, glyphosate-exposed zebrafish have increased OPN
expression as well as skeletal abnormalities, particularly in the spine at the adult stage (2021).
Yoshitake et al. examined OPN¬-deficient mice determined that they were resistant to bone loss,
implying that increased expression of OPN may increase the risk of bone breakage and
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disintegration of bone tissue (1999). Both transcripts have been linked to bone disease such as
osteoporosis and rheumatoid arthritis (Si et al. 2020).

Wnt pathway in somitogenesis is altered by 2,4-DBP exposure
Somites exposed to 2,4-DBP exhibited relative increase in WNT3A expression as well a
significant increase in CCDN1 expression. WNT3A is a part of the canonical Wnt signaling
pathway, which is responsible for inducing osteoblast differentiation (Matsubayashi et al. 2009).
Three key molecules of this pathway are WNT3A, β-catenin, and Cyclin D1 (CCDN1). WNT3A
activates alkaline phosphatase, which is essential in inducing calcification of the bone (O’Neill
2006; Si et al. 2006;). Following WNT3A activity is the accumulation of β-catenin, which
ultimately induces the canonical Wnt signaling pathway. Induction of the pathway promotes
osteogenesis by directly inducing RUNX2 expression, which is a marker for osteoblast
differentiation (Guar et al. 2005). CCDN1 overexpression has been associated with a multitude
of bone-related diseases. Chen et al. conducted a study in adult mice to examine the role of
signaling molecules, including WNT3A and CCDN1, in amyotrophic lateral sclerosis (ALS),
which is characterized by skeletal muscle atrophy that causes weakness in joints, abnormal
fatigue, and impaired bone function. Overall this study found increased expression of CCDN1
and WNT3A in the spinal cord in ALS mice, indicating that abnormal spine formation may be
connected to misexpression of these markers. Belinsky’s study in 2016 examined the
significance of the Wnt signaling pathway in osteogenesis imperfecta, which is commonly
associated with brittle bone disease. In this study, pigment epithelium-derived factor (PEDF)
knockout mice were used to simulate humans with osteogenesis imperfecta. A key takeaway
from this work was that increased WNT3A expression in the PEDF knockout mice impeded
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bone mineralization and continued bone degeneration (Belinsky et al. 2016). As such, abnormal
WNT3A activity can also be responsible for bone disease.
In summary, exposure to 2,4-DBP in HiPS cells altered osteogenic differentiation
through misexpression of genes and proteins which altogether drive bone formation. Overall,
these results indicate that 2,4-DBP, like other SPAs, may contribute to the malformation of the
vertebrae. This study helps to highlight the potential effects of newly characterized contaminants
on human developmental health.
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Figure Legend
Figure 1. 2,4-DBP significantly reduces somitogenesis markers. HiPS cells were
differentiated to somite-like cells for 4 days while exposed to 0, 0.5, or 1.0 µM 2,4-DBP. Cells of
the 0 (A) and 1.0 (B) µM treatments were imaged to assess morphology. Transcript levels of
MEOX1 (C), TBX6 (D), NANOG (E), and OCT4 (F) were determined by qPCR. Data was
normalized using the geometric mean of GAPDH and B2MG and fold changes were calculated
using the 2^ddCt method and expressed as the mean for each group (n=6) with SEM error bars.
Statistical differences (*) were determined using ANOVA with Tukey’s post-hoc test (p < 0.05).

Figure 2. PAX3 expression in dermomyotome-like mesenchymal cells decreases with 2,4DBP exposure. HiPS cells were differentiated to dermomyotome-like for 6 days while exposed
to 0, 0.5, or 1.0 µM 2,4-DBP. Cells of the 0 (A) and 1.0 (B) µM treatments were imaged to
assess morphology. Transcript levels of PAX3 (C) were determined by qPCR. Data was
normalized using the geometric mean of GAPDH and B2MG and fold changes were calculated
using the 2^ddCt method and expressed as the mean for each group (n=6) with SEM error bars.
Statistical differences (*) were determined using ANOVA with Tukey’s post-hoc test (p < 0.05).

Figure 3. Myogenesis is not impacted by exposure to 2,4-DBP. HiPS cells were differentiated
to myoblasts for 40 days while exposed to 0, 0.25, 0.5, or 1.0 µM 2,4-DBP. Cells of the 0 (A)
and 1.0 (B) µM treatments were imaged to assess morphoogy. Transcript levels of PAX3 (C),
MYOG (D), and MYOD (E) while determined by qPCR. Data was normalized using the
geometric mean of GAPDH and B2MG and fold changes were calculated using the 2^ddCt
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method and expressed as the mean for each group (n=6) with SEM error bars. Statistical
differences (*) were determined using ANOVA with Tukey’s post-hoc test (p < 0.05).
Immunohistochemistry was conducted to assess levels of myosin heavy chain (MyHC; green) in
cells, which were counter stained with DAPI (blue) (F).

Figure 4. Formation of sclerotomal-like mesenchymal cells is affected by 2,4-DBP exposure.
HiPS cells were differentiated to sclerotomeal-like cells for 6 days while exposed to 0, 0.5, or 1.0
µM 2,4-DBP. Cells of the 0 (A) and 1.0 (B) µM treatments were imaged to assess morphology.
Transcript levels of PAX1 (C) and PAX9 (D) were determined by qPCR. Data was normalized
using the geometric mean of GAPDH and B2MG and fold changes were calculated using the
2^ddCt method and expressed as the mean for each group (n=6) with SEM error bars. Statistical
differences (*) were determined using ANOVA with Tukey’s post-hoc test (p < 0.05).

Figure 5. Exposure to 2,4-DBP inhibits osteoblast development. HiPS cells were
differentiated to osteoblasts for 40 days while exposed to 0, 0.5, or 1.0 µM 2,4-DBP. Cells of the
0 (A) and (B) 1.0 µM treatments were imaged to assess morphology. Transcript levels of OPN
(C), COL1A1 (D), and RUNX2 (E) were determined by qPCR. Data was normalized using the
geometric mean of GAPDH and B2MG and fold changes were calculated using the 2^ddCt
method and expressed as the mean for each group (n=6) with SEM error bars. Statistical
differences (*) were determined using ANOVA with Tukey’s post-hoc test (p < 0.05).
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Figure 6. 2,4-DBP decreases calcium deposition in osteoblasts but does not significantly
affect cell viability. To detect calcium deposits in osteoblasts, HiPS cells were differentiated to
osteoblasts for 40 days while exposed to 0 (A), 0.25 (B), 0.5 (C), 1.0 (D) µM 2,4-DBP then
stained with Alizarin Red Stain (ARS). ARS was extracted and levels were quantified using
spectrophotometry (E). To assess viability, HiPS cells were differentiated to osteoblasts while
exposed to 0 (F) or 1.0 (G) µM and collected for flow cytometry. Cells were stained with Sytox
Green and Annexin V detect cell viability and apoptosis. Percentages of viable (H) and apoptotic
(I) was calculated. Statistical differences (*) were determined using ANOVA followed by
Tukey’s (p < 0.05).

Figure 7. The Wnt signaling Pathway in somite-like mesenchymal cells formation is
targeted by 2,4-DBP exposure. RNA from HiPS cells differentiated into somite-like
mesemchymal cells, sclerotome-like cells, and myoblasts while exposed to 0 or 1.0 µM 2,4-DBP
was sequenced. A PCA 3D plot was constructed to illustrate the effects of 2,4-DBP at each
differentiation stage. C indicates sclerotomal cells, M indicates myoblasts, and S indicates
somite-like mesenchymal cells. 0DBP indicates control cells, and 1DBP indicates 1.0 µM
exposed cells. GO terms in somites that were affected by 2,4-DBP exposure (B).
Immunoblotting of Wnt3a (C) and β-catenin (D) was then done to verify genes listed in
sequencing data analysis. Western blot data was normalized using GAPDH loading control for
analysis (E,F). Transcript levels of CCDN1 was determined by qPCR (E) qPCR data of CCD1
was normalized using the geometric mean of GAPDH and B2MG and fold changes were
calculated using the 2^ddCt method and expressed as the mean for each group (n=6) with SEM
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error bars (G). Statistical differences (*) were determined using ANOVA with Tukey’s post-hoc
test (p < 0.05)
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CHAPTER 3
Conclusion
Synthetic phenolic antioxidants have been ubiquitously used throughout the world as a
means of enhancing polymer-based products and preserving food. 2,4-DBP has been used
particularly for polyethylene crosspolymer (PEX) water pipes, making drinking water the main
way humans are exposed to this antioxidant (Lund et al. 2011). The purpose of this study, as a
result, is to expand the knowledge of this compound and its effects on human health. Previous
work regarding 2,4-DBP has focused on its presence in human serum, urine, and blood samples
(Wang et al. 2018; Du et al. 2019; Liu & Mabury 2019; Wang & Kannan 2019; Murawski et al.
2021), leaving its toxicity as an unknown factor. 2,4-DBP is also produced by algae and plants,
but studies regarding it natural origins focus on its antioxidant properties for health benefits
rather than its potential toxic effects (Nair et al. 2020; Vahdati et al. 2022). In effect, this study is
important in bringing light to the negative effects of this compound on human development.
In this study, MEOX1 gene expression in somites, PAX9 expression in sclerotomes, OPN
and RUNX2 expression in osteoblasts were perturbed. MEOX1 is an early marker of osteogenesis
at the somite stage and contributes to the formation of the vertebrae (Rodrigo et al. 2004; Skuntz
et al. 2010). 2,4-DBP exposure caused a significant decrease in the expression of this gene,
implying that osteogenesis is already impacted at its early stages. Klippel-Feil syndrome is a rare
disorder in humans characterized by a fused vertebrae which leads to malformations in the neck
and troubles in mobility. The syndrome itself has been correlated with MEOX1 mutations and
deficiencies. (Mohamed et al. 2013; Dauer et al. 2018). Exposed somites also showed decreases
in TBX6, which directs the formation of the posterior paraxial mesoderm, leading to the tail bud
of the embryo (Chapman et al. 2003). TBX6, however, is relevant to skeletal myogenesis, which
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was determined to be less affected by 2,4-DBP exposure (Windner et al. 2015). In sclerotomes,
PAX9 expression targets particularly its dorsal and lateral regions, which is essential in the
formations of the tendons and ligaments of the vertebrae (Mise et al. 2008; Tani et al. 2020).
Finally, disruptions in OPN and RUNX2 in the osteoblast stage overall are correlated with
decreased mineralization (Zurick et al. 2013; Yuan et al. 2014), which ultimately lead to
osteomalacia, or soft bones. In addition to markers of differentiation, markers of pluripotency
had upregulated significantly in somites that were exposed. As such, cells which were treated
2,4-DBP are susceptible to slowed rates of differentiation. Misexpression of these genes in
addition to the visible morphological differences as well as the decrease in calcium deposit
formation indicate that 2,4-DBP primarily impacts the osteogenic pathway.
The results of this study overall have elucidated the concerns of exposure to synthetic
antioxidants and have especially keyed in on the importance of investigating lesser-known
compounds. As copper pipes have been readily replaced with PEX pipes, this work should be
relevant in environmental public health and research should continue to expand upon the
knowledge of 2,4-DBP’s developmental toxicity. Lund et al. determined drinking water to
contain up to 345 µg/L of 2,4-DBP after distributing through PEX pipes (2011). In humans,
urine has been found to contain up to 69.9 µg/L of the compound (Liu et al. 2019). As such, 2,4DBP can be excreted but can also remain in the body. In serum, 2,4-DBP concentrations ranged
up to 14.9 µg/L (Liu & Mabury, 2018). Finally, Du et al. determined 2,4-DBP in various samples
in pregnant women. Cord blood and placenta samples were found at up to 3.5 ng/g and 4.0 ng/g,
respectively (2019). This study examined the effects of concentrations up to 206 µg/L. As such,
the concentrations used for our exposures may well reflect the interactions 2,4-DBP may have
with growth and development. Observing the disruptions in markers of vertebral formation and
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mineralization at these relevant concentrations leads to implications of substantial health risks
further into development. The combination of the vertebral and mineralization perturbations as
well as the retained pluripotency conclude that exposure to 2,4-DBP can lead to significant
malformations and disorders in the developing embryo.
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